SCHEMBL23965889

SCHEMBL23965889

Cc1ccc(-c2ccc3c(c2)c2cc(-c4ccc(C)cc4)ccc2n3-c2ccc(-c3ccc(C#N)cc3)cc2-c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)ccc2-n2c3ccc(-c4ccc(C)cc4)cc3c3cc(-c4ccc(C)cc4)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 10/20 0.41
ABCB1 P08183 6/20 0.39
MAPKAPK2 P49137 1/20 0.38
ALDH1A3 P47895 1/20 0.38
MEN1 O00255 2/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C19 P33261 2/20 0.38
KMT2A Q03164 2/20 0.38
CLK4 Q9HAZ1 2/20 0.38
LMNA P02545 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
PPARG P37231 1/20 0.37
NCOA2 Q15596 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21364338 0.97 PTGER4 (0.40) ABCG2ABCB1MAPKAPK2ALDH1A3MEN1
SCHEMBL21364340 0.96 ABCG2 (0.41) ABCG2ABCB1ALDH1A3MEN1ALDH1A1
SCHEMBL21364840 0.95 ABCG2 (0.39) ABCG2ABCB1MAPKAPK2ALDH1A3MEN1
SCHEMBL21364551 0.94 ABCG2 (0.43) ABCG2ABCB1ALDH1A3MEN1ALDH1A1
SCHEMBL21364344 0.94 ABCG2 (0.43) ABCG2ABCB1ALDH1A3MEN1ALDH1A1
SCHEMBL22243026 0.94 CYP1A2 (0.40) ABCG2ABCB1MAPKAPK2ALDH1A3MEN1
SCHEMBL21364325 0.93 ABCG2 (0.39) ABCG2ABCB1ALDH1A3MEN1ALDH1A1
SCHEMBL22137219 0.93 ABCG2 (0.40) ABCG2ABCB1ALDH1A3MEN1ALDH1A1
SCHEMBL23965894 0.93 L3MBTL1 (0.40) ABCG2ABCB1ALDH1A3MEN1ALDH1A1
SCHEMBL20150414 0.93 KDM4E (0.39) ABCG2ABCB1MAPKAPK2ALDH1A3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161836-B2 Organic molecules for optoelectronic devices CYNORA GMBH (DE) 2021-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161836-B2 Organic molecules for optoelectronic devices OR10J3, OR51E2, OCIAD2 ABCG2 3275/4885ABCB1 1278/4885MAPKAPK2 788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.